The 21st China Association of Clinical Laboratory Practice Expo (CACLP) and the 4th China IVD Supply Chain Expo (CISCE) officially released that the upcoming event will be held from 16 - 18 March 2024 at Chongqing International Expo Center.
CACLP & CISCE 2023 witnessed a record-breaking gathering of over 1,300 exhibitors and approximately 40,000 visitors from 29 countries and regions. Building upon this triumph and in line with our steadfast slogan ¡°Shaping A Smarter Future Through Collaboration¡±, we anticipate another remarkable turnout in 2024 with a continuous growth on both event size and number of attendees.
Notably, the 21st edition of CACLP and the 4th edition of CISCE will come back to the vibrant city of Chongqing after 2021, that is renowned for its impressive landscapes, thriving academic community, cutting-edge technological development, and robust economic growth. As currently and the most populated city and the fourth-largest economic hub in China, Chongqing is home to 32.13 million residents and abundant medical resources with 857 hospitals and 22,243 medical institutions at all levels. It can be expected that Chongqing will offer an open and innovative backdrop for the event that fosters collaboration, inspires new ideas for products and technologies.
CACLP & CISCE has long been recognized as the leading platform for in vitro diagnostics (IVD) institutions and professionals worldwide to explore the latest products and services, get in touch with industry edge information and forge valuable partnerships.
For the 2024 edition, CACLP continues to focus on promoting the integration of academia and commerce, communication and collaboration, innovation and branding in the field of the IVD industry. By actively involving an increasing number of international players, the event aims to unlock more possibilities on a global scale.
Co-located with CACLP, the 4th CISCE will return to Chongqing after 3 years¡¯ development. Upholding the mission to always provide top-quality services and supports to global IVD upstream raw material, key components, and service companies, CISCE continually enhances the linkage and facilitates collaborations among the IVD supply chain. We firmly believe that the two exhibitions will once again actively promote and contribute to the thriving development of the entire IVD industry worldwide.
Along with the tradeshows, participants can also expect an extensive range of engaging academic activities from 15 - 17 March, including the 9th China Experimental Medicine Conference and series sessions, and the 11th China IVD Industry Development Conference and series forums, which will be covering a wide array of topics related to laboratory medicine and IVD and providing stimulating reports, discussions and more importantly, opportunities to connect with renowned experts from research centers and hospitals, and peers from the whole industry.
Further information, including specific schedules, venue details, visitor registration, and exhibitor guidelines will be announced in the coming months. Interested companies and individuals are encouraged to visit CACLP¡¯s official websites, subscribe to the newsletter or follow LinkedIn @CACLP, which will be regularly updated with the latest news and updates.
As Professor Haibo SONG, the chairman of CAIVD (China Association of In-Vitro Diagnostics) and the founder of CACLP, said in the previous interview, ¡°China is a marketplace not only for China but also for the globe, so we will see more international companies coming to China and meanwhile we are also working with and are ready to work for global companies and consumers, and providing a solution in our way.¡±
We eagerly look forward to welcoming researchers, scholars, manufacturers, agents, investors, entrepreneurs, and all IVD-related professionals from across the globe to CACLP & CISCE 2024 and its concurrent activities in Chongqing. Mark your calendars and join us for the Convergence of Laboratory Medicine & IVD and be a part of the global and high-quality IVD community together!
For further information, please visit https://en.caclp.com
Press Contact
Ms. Sudi FANG
sudi.fang@gl-events.com
Tel: +86 21 5255 8222
About GL events
GL events is a world-class leading provider of integrated solutions and services for events operating across the 3 major core divisions: Venues (venue management), Exhibitions (exhibition organizing) and Live (event services).
Through its wide global network made up of more than 90 offices, with organizing over 480 proprietary trade fair and events, managing more than 60 venues, and staging more than 4,200 events every year, GL events Group is a critical force for city promotion of 28 MICE destinations.
Present on five continents with operations in more than 20 countries, GL events has over 5,119 employees. Listed on the Eurolist Euronext Compartment B (Paris Stock Exchange), GL events had a turnover of €1.315bn in 2022.
About CACLP
Debut launched in 1991, CACLP, the China Association of Clinical Laboratory Practice Expo, is well established as one of the largest exhibitions in the in vitro diagnostic industry worldwide. CISCE, China IVD Supply Chain Expo, successfully launched in 2021, further expands the product sectors from upstream to downstream. With a great number of high-level academic and educational programs held concurrently onsite, and year-round promotional solutions, CACLP proves itself as one of the most important platforms for global IVD players.
In 2020, CACLP formed the joint-venture company with GL events to start the internationalism strategy.
